StockData
LIANYOTCPharmaceutical PreparationsFiscal year ends December 31

LianBio

Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q on Nov 13, 2023
$0.06+0.01 (+15.10%)

Close on Oct 19, 2026

Market cap
$6.29M
P/E (TTM)
–
Dividend yield
–

LianBio revenue by segment

No segment breakdown reported

LianBio does not break out revenue by segment, region or product in the tagged data of its filings for this period type.